Current position:Home >Product >
4-[4-(1H-indol-4-yl)-6-(2-propylimidazol-1-yl)-1,3,5-triazin-2-yl]morpholine
4-[4-(1H-indol-4-yl)-6-(2-propylimidazol-1-yl)-1,3,5-triazin-2-yl]morpholine
|
|
Canonical SMILES:
CCCC1=NC=CN1C2=NC(=NC(=N2)C3=C4C=CNC4=CC=C3)N5CCOCC5
Isomeric SMILES
CCCC1=NC=CN1C2=NC(=NC(=N2)C3=C4C=CNC4=CC=C3)N5CCOCC5
InChI
InChI=1S/C21H23N7O/c1-2-4-18-23-9-10-28(18)21-25-19(16-5-3-6-17-15(16)7-8-22-17)24-20(26-21)27-11-13-29-14-12-27/h3,5-10,22H,2,4,11-14H2,1H3
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 4-[4-(1H-indol-4-yl)-6-(2-phenethylimidazol-1-yl)-1,3,5-triazin-2-yl]morpholine
- (11S,17R)-10,13-dimethyl-17-(2-naphthalen-1-yloxyethanoyl)-11,17-bis(oxidanyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
- 4-[4-(1H-indol-4-yl)-6-[2-(phenylmethyl)imidazol-1-yl]-1,3,5-triazin-2-yl]morpholine
- (11S,17R)-10,13-dimethyl-17-(2-naphthalen-2-yloxyethanoyl)-11,17-bis(oxidanyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
- 4-[4-(1H-indol-4-yl)-6-(2-methylindol-1-yl)-1,3,5-triazin-2-yl]morpholine
- 1-[4-(1H-indol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-2-(trifluoromethyl)benzimidazol-5-amine
- (9R,11S,16R,17R)-9-fluoranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-17-[2-(4-phenylmethoxyphenoxy)ethanoyl]-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
- 1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]methylsulfanyl]ethanone
- (9R,11S,16R,17R)-9-fluoranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-17-[2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)ethanoyl]-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
- (6-bromanylpyrazolo[1,5-a]pyrimidin-2-yl)-(1-methyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)methanone

